Research - Novara, Piemonte, Italy
Novaicos is a new biotech company focused on innovative approach for the therapy of bone-loss related diseases. Novaicos develops its patented active substance, the only immune-derived compound at the state-of-the-art with a relevant role in inhibiting bone erosion even in osteoporosis and in bone metastasis, with potential properties as modularity, reversibility and tolerability.
Apache
WordPress.org
Google Font API
Mobile Friendly